QT Imaging Holdings, Inc. filed an S-1 registration statement on November 3, 2025, registering the resale of 29.34 million shares, primarily underlying warrants issued in recent financing rounds. The company is commercializing the QT Breast Scanner through a distribution partnership with NXC, which represents a critical revenue driver.
Financial Performance & Liquidity: The company continues to report significant losses, with Net Loss widening sharply to $15.14 million for the six months ended June 30, 2025 (up from $1.88 million the prior year), resulting in an Accumulated Deficit of
...